David R. McAvoy is General Counsel and CCO at Brickell Biotech, Inc. (BBI). They have made 4 open-market trades across 2 companies since 2020, most recently 2025-09-05.
CIK 0001758842
4 open-market purchases totalling $73K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TEVA | BUY | 2025-09-05 | 2025-09-09 | $18.86 | $21K | -7.1% | +1.5% | +43.4% |
| TEVA | SELL · 10b5-1 | 2025-03-04 | 2025-03-06 | $15.79 | $76K | +7.2% | -9.4% | +13.9% |
| BBI | BUY | 2021-07-23 | 2021-07-27 | $0.67 | $12K | -3.7% | +4.4% | -22.7% |
| BBI | BUY | 2021-05-17 | 2021-05-19 | $0.80 | $21K | -2.2% | -6.8% | -30.1% |
| BBI | BUY | 2020-09-18 | 2020-09-21 | $0.83 | $19K | +4.2% | -1.2% | -15.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.